These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 33611900)
1. [Medication compliance for secondary prevention and long-term outcome among patients with acute coronary syndrome after percutaneous coronary intervention in different regions]. Wang X; Li Y; Li J; Qiu MH; Qi ZZ; Li XY; Li YZ; Na K; Han YL Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):143-149. PubMed ID: 33611900 [No Abstract] [Full Text] [Related]
2. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome]. Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236 [No Abstract] [Full Text] [Related]
3. Analysis of individualized antiplatelet therapy for patients of acute coronary syndrome after percutaneous coronary intervention under the guidance of platelet function: A one-center retrospective cohort study. Dang W; Wang J; Zhang Q; Liu N; Li W; Yao Z Medicine (Baltimore); 2021 Apr; 100(16):e25601. PubMed ID: 33879725 [TBL] [Abstract][Full Text] [Related]
4. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study]. Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427 [No Abstract] [Full Text] [Related]
5. Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease. Jia S; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Yuan J; Song L Circ J; 2020 Sep; 84(10):1718-1727. PubMed ID: 32848116 [TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and prognosis between male and female patients with premature coronary artery disease after intervention]. Tang XF; Song Y; Xu JJ; Wang HH; Jiang L; Jiang P; Yao Y; Zhao XY; Gao Z; Yang YJ; Qiao SB; Gao RL; Xu B; Yuan JQ Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):798-805. PubMed ID: 31648462 [No Abstract] [Full Text] [Related]
7. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial. Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541 [TBL] [Abstract][Full Text] [Related]
8. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar. El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397 [TBL] [Abstract][Full Text] [Related]
9. [Impact of prolonging dual antiplatelet therapy on long-term prognosis of elderly patients with coronary heart disease complicated with diabetes mellitus undergoing drug-eluting stent implantation]. Xu JJ; Zhu P; Song Y; Yuan DS; Jia SD; Zhao XY; Yao Y; Jiang L; Xu N; Li JX; Zhang Y; Song L; Gao LJ; Chen JL; Qiao SB; Yang YJ; Xu B; Gao RL; Yuan JQ Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):450-457. PubMed ID: 35589593 [No Abstract] [Full Text] [Related]
10. A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study. Chen Y; Yin T; Xi S; Zhang S; Yan H; Tang Y; Qian J; Chen J; Su X; Du Z; Wang L; Qin Q; Gao C; Zheng Y; Zhao X; Cheng X; Li Z; Zhang W; Chen H; Wang J; Yang Z; Li H; Liu H; Zhou X; Qu B; Xiang D; Guo Y; Wang L; Nie S; Fu G; Yang M; Cai S Catheter Cardiovasc Interv; 2019 Jun; 93(7):1194-1204. PubMed ID: 31112635 [TBL] [Abstract][Full Text] [Related]
11. [Age-related differences in the management and outcome of acute coronary syndrome under the chest pain center model: a multicenter retrospective study]. Li S; Ding X; Ye T; Cheng L; Cui C; Zhang Y; Zhu F; Jiang X; Cai L Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):318-323. PubMed ID: 33834973 [TBL] [Abstract][Full Text] [Related]
12. Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention. Li Y; Li J; Qiu M; Ma S; Na K; Li X; Qi Z; Chen S; Li Y; Han Y Catheter Cardiovasc Interv; 2022 May; 99 Suppl 1():1395-1402. PubMed ID: 35032148 [TBL] [Abstract][Full Text] [Related]
13. Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study. Ma S; Jiang Z; Qiu M; Li Z; Bian L; Li Y; Han Y Adv Ther; 2020 Jul; 37(7):3150-3161. PubMed ID: 32418142 [TBL] [Abstract][Full Text] [Related]
14. [The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention]. Na K; Li MY; Qiu MH; Li J; Liu R; Li Y; Han YL Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Nov; 49(11):1117-1123. PubMed ID: 34775722 [No Abstract] [Full Text] [Related]
15. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention. Byun JK; Choi BG; Rha SW; Choi SY; Jeong MH; Atherosclerosis; 2018 Oct; 277():130-135. PubMed ID: 30212681 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome. Li D; Sun Y; Ye X; Li L; Chen Y; Wang D Adv Ther; 2022 Jan; 39(1):754-766. PubMed ID: 34904209 [TBL] [Abstract][Full Text] [Related]
17. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction. Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583 [TBL] [Abstract][Full Text] [Related]
18. Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study. Na K; Qiu M; Wei N; Li J; Yan C; Li J; Li Y; Han Y Front Cardiovasc Med; 2023; 10():1201091. PubMed ID: 37745130 [TBL] [Abstract][Full Text] [Related]
19. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233 [TBL] [Abstract][Full Text] [Related]
20. [Effects of clopidogrel resistence and CYP2C19 genotype on the clinical prognosis of patients with acute coronary syndrome undergoing percutaneous coronary intervention]. He CB; Li Q; Ye YC; Zhao XL; Tu CC; Zeng Y Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):765-771. PubMed ID: 32957760 [No Abstract] [Full Text] [Related] [Next] [New Search]